3Wolf DM, Friedrichs I, Toma AG. Lymphocyte-white blood cell count ratio: a quickly available screening tool to differentiate acute purulent tonsillitis from glandular fever. Arch Otolaryngol Head Neck Surg, 2007,133: 61-64.
4Tattevin P, Le Tulzo Y, Minjolle S, et al. Increasing ineidenee of severe Epstein-Barr virus-related infeetious mononueleosis: surveillanee study. J Clin Mierobiol, 2006, 44:1873-1874.
5Kimura H, Hoshino Y, Hara S, et al. Differences between T cell-type and natural killer cell-type chronic active Epstein-Barr virus infection. J Infect Dis, 2005, 191: 531-539.
6Katano H, Ali MA, Patera AC, et al. Chronic active Epstein-Barr virus infection associated with mutations in perforin that impair its maturation. Blood, 2004, 103: 1244-1252.
7Moutsehen M, Leonard P, Sokal EM, et al. Phase Ⅰ/Ⅱ studies to evaluate safety and immunogenieity of a recombinant gp350 Epstein-Barr virus vaccine in healthy adults. Vaccine, 2007,25: 4697-4705.
